Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Cell Therapeutics' FDA Panel: Live Blog
TheStreet.com
Monday, March 22, 2010 - 9:51am
tags:
FDA, Cell Therapeutics, pixantrone, lymphoma
Health-Care Bill Hits Euro Drugmakers
Forbes
Monday, March 22, 2010 - 9:01am
tags:
healthcare bill, Roche, AstraZeneca, GSK, Novartis, healthcare reform
Healthcare Reform Limits Further Pain for Pharmas
Seeking Alpha
Sunday, March 21, 2010 - 10:04am
tags:
healthcare reform
Bitter financial pills for drug makers
Washington Post, DC
Sunday, March 21, 2010 - 9:55am
tags:
off-label
Sinovac Finds India Partner for H1N1 Vaccine
Seeking Alpha
Sunday, March 21, 2010 - 9:49am
tags:
Sinovac, India, vaccines, H1N1
When drug makers' profits outweigh penalties
Washington Post, DC
Sunday, March 21, 2010 - 9:47am
tags:
off-label, Bextra, Pfizer, Pharmacia
Warner Chilcott: Prescription Drug Company Offering Exceptional Value
Seeking Alpha
Sunday, March 21, 2010 - 9:44am
tags:
Warner Chilcott
China Biotech Week in Review: China Offers Lion's Share of Emerging Market Growth
Seeking Alpha
Sunday, March 21, 2010 - 9:26am
tags:
China, Novartis, China Sky One Medical
Reckitt Benckiser buys back narcotic addition drug rights from Merck for $153 million
Yahoo/AP
Sunday, March 21, 2010 - 9:21am
tags:
Reckitt Benckiser, Merck, narcotics, Suboxone, Subutex, Temgesic
Why Pfizer's Better Off Without Ratiopharm
Motley Fool
Saturday, March 20, 2010 - 11:42am
tags:
Pfizer, Ratiopharm, Teva Pharmaceuticals, M&A
Medtronic Wins Backing for First MRI-Safe Pacemaker
Bloomberg
Saturday, March 20, 2010 - 11:41am
tags:
pacemakers, Medtronic
How AstraZeneca Is Turning the Tide in Its Legal War Over Antipsychotic Drugs
BNET Pharma
Saturday, March 20, 2010 - 11:40am
tags:
AstraZeneca, lawsuits, Seroquel, antipsychotics
The Rush To Buy ImmunoGen
Seeking Alpha
Saturday, March 20, 2010 - 11:38am
tags:
Immunogen
Why Doing Something About ‘Pay for Delay’ Will Have to Wait
WSJ Online
Saturday, March 20, 2010 - 11:37am
tags:
pay-for-delay, healthcare reform
Medicines Co. says patent extension denied
Marketwatch
Saturday, March 20, 2010 - 11:35am
tags:
Medicines Company, patents, blood thinners, Angiomax
Glaxo's Asthma Drug Looks Increasingly Bullet-Proof
Seeking Alpha
Saturday, March 20, 2010 - 11:34am
tags:
GSK, asthma, Vectura, Sandoz, generics, Advair
FDA warns Zocor, Vytorin raise muscle injury risk
Marketwatch
Saturday, March 20, 2010 - 11:32am
tags:
FDA, Zocor, Vytorin, Merck
Roche CEO Schwan Puts Science First in Pursuing Deals
Businessweek
Friday, March 19, 2010 - 10:50am
tags:
Roche, Pharma CEOs, Severin Schwan, M&A
A.P. Pharma nausea drug hit with FDA rejection
Fierce Biotech
Friday, March 19, 2010 - 10:48am
tags:
FDA, AP Pharma
Astellas Pharma meets antitrust condition in takeover attempt of OSI Pharmaceuticals
Yahoo/AP
Friday, March 19, 2010 - 10:33am
tags:
Astellas, OSI Pharmaceuticals, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.